Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage

Clinical trial NCT03926624 · TERMINATED

Trial details

NCT number: NCT03926624
Sponsor: Delta-Fly Pharma, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2019-11-22
Primary completion: 2026-01-07
Enrollment: 167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.